Leuko-araiosis: an ancient term for a new problem, Can J Neurol Sci, vol.13, pp.533-537, 1986. ,
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration, Lancet Neurol, vol.12, pp.822-860, 2013. ,
Pathogenesis of leukoaraiosis: a review, Stroke, vol.28, pp.652-661, 1997. ,
Cardiovascular disease and brain health: focus on white matter hyper-intensities, Int J Cardiol Heart Vasc, vol.19, pp.63-72, 2018. ,
Cerebral amyloid angiopathy in the elderly, Ann Neurol, vol.70, pp.871-80, 2011. ,
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging, Lancet Neurol, vol.12, pp.483-97, 2013. ,
Inflammation and cerebral small vessel disease: a systematic review, Ageing Res Rev, vol.53, p.100916, 2019. ,
Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease, Acta Neuropathol, vol.134, pp.459-73, 2017. ,
White matter hyper-intensities, cognitive impairment and dementia: an update, Nat Rev Neurol, vol.11, pp.157-65, 2015. ,
MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging, AJR Am J Roentgenol, vol.149, pp.351-357, 1987. ,
Automatic detection of white matter hyper-intensities in healthy aging and pathology using magnetic resonance imaging: a review, Neuroinformatics, vol.13, pp.261-76, 2015. ,
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan study, J Neurol Neurosurg Psychiatry, vol.70, pp.9-14, 2001. ,
Prevalence of white matter hyper-intensities in a young healthy population, J Neuroimaging, vol.16, pp.243-51, 2006. ,
White matter lesions: spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy, Neurology, vol.91, pp.964-75, 2018. ,
Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI, Circ Cardiovasc Genet, vol.8, pp.398-409, 2015. ,
Longitudinal study of blood pressure and white matter hyper-intensities: the EVA MRI cohort, Neurology, vol.56, pp.921-927, 2001. ,
Associations between vascular risk factors and brain MRI indices in UK Biobank, Eur Heart J, vol.40, pp.2290-300, 2019. ,
The clinical importance of white matter hyper-intensities on brain magnetic resonance imaging: systematic review and meta-analysis, BMJ, vol.341, p.3666, 2010. ,
, Diagnostic and statistical manual of mental disorders: DSM-5, 2013.
Impact of multiple pathologies on the threshold for clinically overt dementia, Acta Neuropathol, vol.134, pp.171-86, 2017. ,
Vascular subcortical hyper-intensities predict conversion to vascular and mixed dementia in MCI patients, Stroke, vol.39, pp.2046-51, 2008. ,
White matter hyper-intensities relate to clinical progression in subjective cognitive decline, Stroke, vol.46, pp.2661-2665, 2015. ,
The association between cognitive function and white matter lesion location in older adults: a systematic review, BMC Neurol, vol.12, p.126, 2012. ,
Presence and progression of white matter hyper-intensities and cognition: a meta-analysis, Neurology, vol.82, pp.2127-2165, 2014. ,
Neuropsychiatric correlates of white matter hyper-intensities in Alzheimer's disease, Int J Geriatr Psychiatry, vol.25, pp.780-788, 2010. ,
White matter hyper-intensities in late life depression: a systematic review, J Neurol Neurosurg Psychiatry, vol.79, pp.619-643, 2007. ,
Changes in white matter as determinant of global functional decline in older independent outpatients: three-year follow-up of LADIS (leukoaraiosis and disability) study cohort, BMJ, vol.339, p.2477, 2009. ,
Risk of nursing home admission in cerebral small vessel disease, Stroke, vol.49, pp.2659-65, 2018. ,
Prospective association of white matter hyperintensity volume and frailty in older adults, Exp Gerontol, vol.118, pp.51-55, 2019. ,
White matter hyper-intensities are associated with falls in older people with dementia, Brain Imaging Behav, vol.13, pp.1265-72, 2018. ,
Physical activity, motor function, and white matter hyperintensity burden in healthy older adults, Neurology, vol.84, pp.1294-300, 2015. ,
Deep white matter hyper-intensities, microstructural integrity and dual task walking in older people, Brain Imaging Behav, vol.12, pp.1488-96, 2018. ,
, G Model REVMED-5852; No. of Pages 10
Brain white matter hyper-intensities, executive dysfunction, instability, and falls in older people: a prospective cohort study, J Gerontol A Biol Sci Med Sci, vol.67, pp.1085-91, 2012. ,
Urinary complaints in non-disabled elderly people with age-related white matter changes: the leukoaraiosis and disability (LADIS) study, J Am Geriatr Soc, vol.56, pp.1638-1681, 2008. ,
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease, Lancet, vol.354, pp.919-939, 1999. ,
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders, Nat Rev Neurosci, vol.12, pp.723-761, 2011. ,
White matter hyper-intensities predict amyloid increase in Alzheimer's disease, Neurobiol Aging, vol.33, pp.2766-73, 2012. ,
White matter hyper-intensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network: white matter hyper-intensities in familial AD, Ann Neurol, vol.79, pp.929-968, 2016. ,
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, vol.352, pp.1347-51, 1998. ,
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial, Lancet Neurol, vol.7, pp.683-692, 2008. ,
Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial, Lancet Neurol, vol.13, pp.1177-85, 2014. ,
Effect of intensive vs. standard blood pressure control on probable dementia: a randomised clinical trial, JAMA, vol.12, pp.553-61, 2019. ,
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomised clinical trial, JAMA Intern Med, vol.174, pp.324-357, 2014. ,
Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis, Stroke, vol.49, pp.1531-1534, 2018. ,
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke, N Engl J Med, vol.367, pp.817-842, 2012. ,
Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomised trials, Stroke, vol.46, pp.1014-1037, 2015. ,
ASPREE-NEURO study protocol: a randomised controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyper-intensities, cognition, and stroke in the healthy elderly, Int J Stroke, vol.12, pp.108-121, 2017. ,
Effect of pravastatin on cerebral infarcts and white matter lesions, Neurology, vol.64, pp.1807-1816, 2005. ,
Effects of sartans and lowdose statins on cerebral white matter hyper-intensities and cognitive function in older patients with hypertension: a randomised, double-blind and placebocontrolled clinical trial, Hypertens Res, vol.42, pp.717-746, 2019. ,
Effect of low-dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: a subgroup analysis of a randomised clinical trial, J Am Med Dir Assoc, vol.19, pp.995-1002, 2018. ,
A systematic review of MRI studies examining the relationship between physical fitness and activity and the white matter of the ageing brain, Neuroimage, vol.131, pp.81-90, 2016. ,
Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL Active trial, Neurobiol Aging, issue.19, pp.30155-30156, 2019. ,
Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study, Arch Neurol, vol.69, pp.251-257, 2012. ,
Fish consumption and risk of subclinical brain abnormalities on MRI in older adults, Neurology, vol.71, pp.439-485, 2008. ,
Randomised trial of marine n-3 polyunsaturated fatty acids for the prevention of cerebral small vessel disease and inflammation in aging (PUFA trial): rationale, design and baseline results, Nutrients, vol.11, p.735, 2019. ,
B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke, Stroke, vol.43, pp.3266-70, 2012. ,
Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion, Brain Res, vol.1646, pp.494-503, 2016. ,
Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the Evaluation of Vascular care in Alzheimer's disease (EVA) study, Stroke, vol.41, pp.554-560, 2010. ,
Brain and white matter hyperintensity volumes after 10 years of random assignment to lifestyle intervention, Diabetes Care, vol.39, pp.764-71, 2016. ,
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention study to prevent cognitive impairment and disability (FINGER), Alzheimers Res Ther, vol.11, p.53, 2019. ,
Effect of long-term vascular care on progression of cerebrovascular lesions: magnetic resonance imaging substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care), Stroke, vol.48, pp.1842-1850, 2017. ,
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials, Lancet Neurol, vol.6, pp.782-92, 2007. ,
The Age-Well randomised controlled trial of the Medit-Ageing European project: effect of meditation or foreign language training on brain and mental health in older adults, Alzheimers Dement, vol.4, pp.714-737, 2018. ,
An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis, Neuroimage, vol.59, pp.3774-83, 2012. ,